Bradford K. Amman's most recent trade in Vivos Therapeutics Inc was a trade of 149,533 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 26, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vivos Therapeutics Inc | Bradford Amman K. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 149,533 | 180,533 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | Bradford K. Amman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,000 | 31,667 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | Bradford K. Amman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2022 | 200,000 | 500,001 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | Bradford K. Amman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | Bradford K. Amman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | Bradford K. Amman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 83,334 | 83,334 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | Bradford K. Amman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | Bradford K. Amman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 16,667 | 16,667 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | Bradford K. Amman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.29 per share. | 25 May 2021 | 1,000 | 2,000 | - | 5.3 | 5,290 | Common Stock |
| Vivos Therapeutics Inc | Bradford K. Amman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 100,000 | 200,001 | - | - | Stock Option |